Prospective evaluation of physical activity in patients with idiopathic scoliosis or kyphosis receiving brace treatment

Bracing is an established method of conservative treatment for adolescent idiopathic scoliosis and kyphosis. Compliance among adolescents is frequently inadequate due to the discomfort of wearing a brace, cosmetic issues, and fear on the part of patients and parents that bracing may reduce everyday physical activities. The aim of this prospective, controlled study was to objectify the impact of spinal bracing on daily step activity in patients receiving conservative treatment for adolescent idiopathic scoliosis (AIS) or adolescent kyphosis (AK). Forty-eight consecutive patients (mean age 13.4 ± 2.3 years), consisting of 38 AIS patients (33 girls, 5 boys) and 10 AK patients (6 girls, 4 boys) were included. Once the decision to carry out bracing had been taken and while the patients were waiting for the individual brace to be built, step activity was assessed without braces by means of step activity monitoring (SAM) for seven consecutive days. After 8 weeks of brace wearing, step activity was assessed during regular brace treatment, again for seven consecutive days. In addition, brace-wearing times were simultaneously recorded using temperature probes implanted in the braces to measure compliance. Before and during brace treatment, patients completed the Scoliosis Research Society (SRS-22) questionnaire. The SAM was worn for an average of 12.7 ± 1.5 h/day during the first measurement and 12.3 ± 1.9 h on average during the second measurement. The mean gait cycles (GCs) per day and per hour before treatment were 5,036 ± 1,465 and 395 ± 105, respectively. No significant reduction in step activity was found at the follow-up measurement during bracing, at 4,880 ± 1,529 GCs/day and 403 ± 144 GCs/h. Taking the 23-h recommended time for brace wearing as a basis (100%), patients wore the brace for 72.7 ± 27.6% of the prescribed time, indicating an acceptable level of compliance. Girls showed a higher compliance level (75.6 ± 25.6%) in comparison with boys (56.7 ± 31.9%), although the difference was not significant (P = 0.093). The SRS-22 total score showed no differences between the two measurements (2.57 ± 0.23 vs. 2.56 ± 0.28). Implementing a simultaneous and objective method of assessing step activity and brace-wearing times in everyday life proved to be feasible, and it expands the information available regarding the impact of bracing on patients’ quality of life. The results clearly show that brace treatment does not negatively interfere with daily step activity in AIS and AK patients. This is an important finding that should help reduce patients’ and parents’ worries concerning bracing.     

Distribution of intrahepatic T, NK and CD3(+)CD56(+)NKT cells alters after liver transplantation: Shift from innate to adaptive immunity?

Background

The liver is an immunological organ containing a large number of T, NK and NKT cells, but little is known about intrahepatic immunity after LTx. Here, we investigated whether the distribution of T, NK and CD3⁺CD56⁺NKT cells is altered in transplanted livers under different circumstances.

Methods

Core biopsies of transplanted livers were stained with antibodies against CD3 and CD56. Several cell populations including T (CD3⁺CD56^-), NK (CD3^-CD56⁺) and NKT cells (CD3⁺CD56⁺) were studied by fluorescence microscopy. Cell numbers were analyzed in relation to the time interval after LTx, immunosuppressive therapy and stage of acute graft rejection (measured with the rejection activity index: RAI) compared to tumor free liver tissue from patients after liver resection due to metastatic disease as control.

Results

Recruitment of CD3⁺CD56⁺NKT cells revealed a significant decrease during high RAI scores in comparison to low and middle RAI scores (RAI 7-9: 0.03 ± 0.01/HPF vs. RAI 4-6: 0.1 ± 0.005/HPF). CD3⁺CD56⁺NKT cells were also lower during immunosuppressive therapy with tacrolimus (0.03 ± 0.01/HPF) than with cyclosporine (0.1 ± 0.003/HPF), cyclosporine/MMF (0.1 ± 0.003/HPF) or sirolimus (0.1 ± 0.01/HPF) treatment. Intrahepatic T cell numbers increased significantly 50 days after LTx compared to control liver tissue (4.5 ± 0.2/HPF vs. 1.9 ± 0.1/HPF). In contrast, NK cells (0.3 ± 0.004/HPF) were significantly fewer in all biopsies after LTx compared to the control (0.7 ± 0.04/HPF).

Conclusions

These data indicate significant alterations in the hepatic recruitment of T, NK and CD3⁺CD56⁺NKT cells after LTx. The increase in T cells and the decrease in NK and CD3⁺CD56⁺NKT cells suggest a shift from innate to adaptive hepatic immunity in the liver graft.     

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir,in solid organ transplant recipients

Antiviral prophylaxis has proved successful for prevention of cytomegalovirus (CMV) disease in solid organ transplant (SOT) patients; though emerging data suggest that antiviral agents interfere with immunity, and may inhibit immune priming. In this context, we investigated levels and phenotype of primary CMV‐specific immune responses that developed during antiviral prophylaxis in a cohort of CMV seronegative recipients (R^?) of a SOT from a seropositive donor (D⁺). We longitudinally monitored CMV viral load, antibodies and levels of the negative immuno‐modulator IL‐10. PBMC were stimulated with CMV‐specific peptide libraries to measure CD137 activation marker on CMV‐specific T‐cells and levels of PD‐1 receptor, which is over expressed on exhausted T‐cells. Unexpectedly, the majority (13/18) of D⁺R^? patients who developed a primary CMV response showed early post‐transplant CMV‐specific responses, though levels of PD‐1 on CMV‐specific T‐cells remained elevated throughout prophylaxis. A strong inverse association was found between levels of plasma IL‐10 and CMV‐specific cellular immune responses. Our study suggests that during prophylaxis, subclinical CMV infection might have occurred in the D⁺R^? patients, and primary CMV‐specific responses were detected early post‐transplant when levels of plasma IL‐10 were low. Extended prophylaxis or antiviral treatment did not appear to suppress CMV‐specific antibodies or T‐cells, which, however, showed exhaustion phenotypes.     

How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure

During the past 3 years, seven potential candidates for mechanical circulatory support (MCS) were treated at our center. Ultimately, only one of them needed MCS (extracorporeal membrane oxygenation [ECMO] for 16 days), although 5 years earlier, all would have been considered for MCS at our center. Seven consecutive patients were seen in this period: four toddlers (three suffering from fulminant myocarditis and one with dilated cardiomyopathy associated with spongy myocardium) and three adolescents (two with postmyocarditis cardiomyopathy and one with hypertrophic cardiomyopathy and severe restrictive dysfunction after an ischemic event with cardiopulmonary resuscitation [stunned heart]). All patients presented in acute cardiocirculatory decompensation. All were admitted to the intensive care unit (ICU); all but one were sedated and intubated. A combination of levosimendan, milrinone, and nesiritide was administered to all patients. Use of catecholamines was kept short (<48 h in six individuals). MCS (ECMO, Berlin Heart Excor Pediatric, and Heartware) was always available. MCS initiation was indicated in only one patient, who was developing progressive multiorgan failure (MOF). The three toddlers with myocarditis recovered with complete normalization of myocardial function within 6 months. The fourth toddler is still at the ICU while waiting for transplantation. The three adolescents were listed with high urgency for heart transplantation, and all received a graft within 3 weeks. The adolescent with the stunned heart developed progressive MOF and was successfully supported with ECMO until transplantation. All six patients with completed course were discharged home in New York Heart Association Heart Failure Functional Classification System I condition without neurological deficits. Combined use of levosimendan, milrinone, and nesiritide, avoidance of catecholamines as much as possible, and MCS as backup are the new strategies at our center. This cardioprotective approach gives excellent outcome at lower risk and better cost-effectiveness in our pediatric patients with acute heart failure. Pediatric trials are recommended to evaluate combined use of newer cardioprotective drugs.     

Parental palliative cancer: psychosocial adjustment and health-related quality of life in adolescents participating in a German family counselling service

Background

Parental palliative disease is a family affair, however adolescent's well-being and coping are still rarely considered. The objectives of this paper were a) to identify differences in psychosocial adjustment and health-related quality of life (HRQoL) among adolescents and young adults with parents suffering from palliative cancer or cancers in other disease stages, b) to relate psychosocial adjustment and health-related quality of life to adolescent coping, and c) to explore significant mediator and predictor variables.

Methods

Cross-sectional data were derived from a multi-site research study of families before child-centered counselling. N=86 adolescents and young adults were included, their mean age 13.78 years (sd 2.45), 56% being female. Performed analyses included ANCOVA, multiple linear regression, and mediation analysis.

Results

Adolescents with parents suffering from palliative cancers reported significantly less total psychosocial problems, and better overall HRQoL. There were no significant group differences regarding coping frequency and efficacy. Our set of coping items significantly mediated the effect of parental disease stage on psychosocial problems and HRQoL. Further, parental disease status and general family functioning predicted psychosocial problems (R²_adj =.390) and HRQoL (R²_adj =.239) best.

Conclusion

The study indicates distress among adolescents throughout the entire parental disease process. Our analysis suggests that counselling services could offer supportive interventions which focus particularly on adolescent coping as well as family functioning.

     

Abnormal neural oscillations in schizotypy during a visual working memory task: support for a deficient top-down network?

Neural oscillatory deficits have been proposed to be a core feature of schizophrenia spectrum disorders. In this study we aimed to confirm this by examining early evoked oscillatory patterns in the EEG theta, beta and gamma bands in individuals with high schizotypal personality trait scores. We carried out an event-related experiment using a computerised delayed matching to sample working memory (WM) task on a sample of volunteers scoring high or low on the Schizotypal Personality Questionnaire (SPQ). Phase-locking factor (PLF), a measure of network synchronisation, was reduced in the beta and gamma bands in two distinct topographical regions (fronto-central and centraloccipital). In addition, signal power in the beta band was decreased in the high schizotypy group in the same fronto-occipital network. These findings suggest that abnormalities in functional connectivity, already described in schizophrenia, extend to schizotypy. Further, the pattern and latency of the altered neural oscillations in the high schizotypy group suggests a deficient modulation of the sensory processing by higher-order structures. Such top-down deficits have been reported in schizophrenia and this data supports the idea that top-down dysfunction is a vulnerability trait that is independent of disease course, medication or symptom severity.